Use of Serial Multi-Template Liquid Biopsies in Triple Negative Breast Cancer Monitoring
Cynvenio Biosystems, Inc.
LiquidBiopsy Test Case: Genomic Analysis of Cerebrospinal Fluid by LiquidBiopsy®
ClearID TNBC Research Study ASCO 2017 Poster Highlights
LiquidBiopsy in metastatic breast cancer: a novel diagnostic platform for next generation sequencing of tumor cells from blood
Cynvenio Biosystems, Inc. and Kimmel Cancer Center at Thomas Jefferson School of Medicin
Classifying circulating, mutation bearing tumor cells from breast cancer patients
Cynvenio Biosystems, Inc, Fox Chase Cancer Center, Jefferson Medical College of Thomas Jefferson University
Targeted Next Generation Sequencing (NGS) of Circulating Tumor Cells (CTCs) and Matched Primary Tumors
Norris Comprehensive Cancer Center – USC, Cynvenio Biosystems Inc., Life Technologies
Capture or detection – where are we missing tumor cells?
Fox Chase Cancer Center and Cynvenio Biosystems Inc.
Profiling the Tumor Genome using Circulating Tumor Cells
Foundation Medicine Inc., Cynvenio Biosystems Inc., and Breastlink Research Group